Alligator Bioscience AB - Company Review
Alligator Bioscience AB - Company ReviewSummary
Alligator Bioscience AB (Alligator Bioscience) is a biotechnology company that discovers and develops antibody based immunotherapies for the treatment of cancer. The company develops immuno-oncology compounds using its proprietary technology platforms, Alligator-Gold, a synthetic svFv library which contains several billion distinct fully human antibodies; and fragment induced diversity (FIND), an in vitro based antibody and protein optimization technology. It also conducts research and development of early stage drug candidates. The company has partnership with various biotechnology companies and others. Alligator Bioscience is headquartered in Lund, Sweden.
This comprehensive company report of Alligator Bioscience AB provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.